Results 111 to 120 of about 3,945 (173)

CCHFV tecVLP morphology and glycoprotein-mediated entry.

, 2015
(A) Representative electron microscopy images of tecVLP. (B) Neutralization of tecVLP entry into SW-13 cells by previously reported monoclonal antibodies (mAbs). 11E7 and 12A9 are CCHFV neutralizing antibodies targeting the glycoprotein Gc; 13G8 is a non-
Scott D. Pegan (832047), Marko Zivcec (191739), Christina F. Spiropoulou (139312), César G. Albariño (139297), Maureen G. Metcalfe (309827), Éric Bergeron (5663428), Lisa W. Guerrero (832046)   +6 more
core   +1 more source

Growth kinetics of CCHFV derived from cDNA.

, 2015
(A) BSR-T7/5 and (B) A549 cells were infected with 0.001 of 50% tissue culture infective dose (TCID50)/cell of cDNA-derived CCHFV (circles) or parental virus isolate from Nigeria (squares). Viral titers were measured daily.
Marko Zivcec (191739), Christina F. Spiropoulou (139312), César G. Albariño (139297), Ayan K. Chakrabarti (139299), Stuart T. Nichol (130422), Éric Bergeron (5663428)   +5 more
core   +1 more source

Evaluation of the biological effects of mutation of the CCHFV nucleocapsid DEVD domain on viral replication

, 2017
Background: Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic viral disease that is asymptomatic in infected animals, but a serious threat to humans.
Bergeron, Éric, Karlberg, Helen, Bell Sakyi, Lesley, Monteil, Vanessa, SALATA, CRISTIANO, Mirazimi, Ali   +5 more
core  

The growing public health concern of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)

The growing public health concern of Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Mohammad M. Sajadi and Scott D.
Mohammad M. Sajadi, Scott D. Pegan
core   +1 more source

Viral dissemination and diagnostic insights from experimental infection of sheep with Crimean-Congo hemorrhagic fever virus. [PDF]

Npj Viruses
Gutjahr B, Michaely LM, Bost C, Sadeghi B, Tomaz F, Keller M, Reiche S, Mirazimi A, Richt JA, Hensley L, Diederich S, Streitz M, Balkema-Buschmann A, Groschup MH, Fischer K.   +14 more
europepmc   +1 more source

Dual-antigen AdV5 vaccines against Crimean-Congo hemorrhagic fever virus induce superior humoral and Th1-biased cellular immunity. [PDF]

Sci Rep
Hanifehnezhad A, Oztop S, Tavukcuoglu E, Tanyeri Y, Yoyler E, Gokce Tepeli G, Unal N, Bozkir A, Karaoglu MT, Esendagli G, Kara A, Gurdal H, Ozkul A.   +12 more
europepmc   +1 more source

Structural and mechanistic insights into protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus nucleocapsid protein. [PDF]

Nat Commun
Moresco V, Garrison AR, Edmundo CA, Fitzpatrick CJ, Karaaslan E, Olschner SP, Ricks KM, Ogundare OT, Tadri L, Carey BD, Sajadi MM, Bergeron É, Golden JW, Pegan SD.   +13 more
europepmc   +1 more source

African tick-borne viruses: A systematic review of diversity, epidemiology, clinical impact, and one health strategies. [PDF]

Vet Res Commun
Makwarela TG, Seoraj-Pillai N, Nangammbi TC.   +2 more
europepmc   +1 more source

Side-by-side evaluation of two Crimean-Congo hemorrhagic fever virus isolates in IFNAR^-/- mice. [PDF]

Npj Viruses
Rohde C, Werner AD, Gellhorn Serra M, Emmerich P, Knap N, Eickmann M, Becker S, Krähling V, Kupke A, BSL4 Animal Facility Team.   +9 more
europepmc   +1 more source

Genetic heterogeneity and pathogenic potential of historical Crimean-Congo hemorrhagic fever virus isolates in China. [PDF]

Virol Sin
Moming A, Bai Y, Zhu Q, Jin J, Fang Y, Huang S, Wu Q, Su Z, Zhao G, Tang S, Wang M, Hu Z, Zhang Y, Deng F, Shen S.   +14 more
europepmc   +1 more source